2014 in New Drugs | As seen in C&EN.
Datamonitor Healthcare referenced in latest cover story
2014 was a busy year in the pharmaceutical industry. It was a year full of M&A activity, unprecedented levels of financing, and a peak in new drug approvals. The FDA gave the green light for 41 new molecular entities – the biggest crop in nearly two decades. This has been seen to signal a reeturn to innovation for an industry that just five years ago seemed stagnant.
C&EN have produced their annual “The Year in New Drugs” cover story with a little help from Datamonitor Healthcare. Some of our forecast data was used to assist in this report.
You can read the full story, or download it, here.
Posted in Latest Research.